Cargando…
The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics
BACKGROUND: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207528/ https://www.ncbi.nlm.nih.gov/pubmed/35733780 http://dx.doi.org/10.3389/fendo.2022.868364 |
_version_ | 1784729551848341504 |
---|---|
author | Vejrazkova, Daniela Vankova, Marketa Vcelak, Josef Krejci, Hana Anderlova, Katerina Tura, Andrea Pacini, Giovanni Sumova, Alena Sladek, Martin Bendlova, Bela |
author_facet | Vejrazkova, Daniela Vankova, Marketa Vcelak, Josef Krejci, Hana Anderlova, Katerina Tura, Andrea Pacini, Giovanni Sumova, Alena Sladek, Martin Bendlova, Bela |
author_sort | Vejrazkova, Daniela |
collection | PubMed |
description | BACKGROUND: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. RESULTS: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. CONCLUSION: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals. |
format | Online Article Text |
id | pubmed-9207528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92075282022-06-21 The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics Vejrazkova, Daniela Vankova, Marketa Vcelak, Josef Krejci, Hana Anderlova, Katerina Tura, Andrea Pacini, Giovanni Sumova, Alena Sladek, Martin Bendlova, Bela Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The MTNR1B gene encodes a receptor for melatonin, a hormone regulating biorhythms. Disruptions in biorhythms contribute to the development of type 2 diabetes mellitus (T2DM). Genetic studies suggest that variability in the MTNR1B gene affects T2DM development. Our aim was to compare the distribution of the genetic variant rs10830963 between persons differing in glucose tolerance in a sample of the Czech population (N=1206). We also evaluated possible associations of the polymorphism with insulin sensitivity, beta cell function, with the shape of glucose, insulin and C-peptide trajectories measured 7 times during a 3-hour oral glucose tolerance test (OGTT) and with glucagon response. In a subgroup of 268 volunteers we also evaluated sleep patterns and biorhythm. RESULTS: 13 persons were diagnosed with T2DM, 119 had impaired fasting blood glucose (IFG) and/or impaired glucose tolerance (IGT). 1074 participants showed normal results and formed a control group. A higher frequency of minor allele G was found in the IFG/IGT group in comparison with controls. The GG constellation was present in 23% of diabetics, in 17% of IFG/IGT probands and in 11% of controls. Compared to CC and CG genotypes, GG homozygotes showed higher stimulated glycemia levels during the OGTT. Homozygous as well as heterozygous carriers of the G allele showed lower very early phase of insulin and C-peptide secretion with unchanged insulin sensitivity. These differences remained significant after excluding diabetics and the IFG/IGT group from the analysis. No associations of the genotype with the shape of OGTT-based trajectories, with glucagon or with chronobiological patterns were observed. However, the shape of the trajectories differed significantly between men and women. CONCLUSION: In a representative sample of the Czech population, the G allele of the rs10830963 polymorphism is associated with impaired early phase of beta cell function, and this is evident even in healthy individuals. Frontiers Media S.A. 2022-06-06 /pmc/articles/PMC9207528/ /pubmed/35733780 http://dx.doi.org/10.3389/fendo.2022.868364 Text en Copyright © 2022 Vejrazkova, Vankova, Vcelak, Krejci, Anderlova, Tura, Pacini, Sumova, Sladek and Bendlova https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Vejrazkova, Daniela Vankova, Marketa Vcelak, Josef Krejci, Hana Anderlova, Katerina Tura, Andrea Pacini, Giovanni Sumova, Alena Sladek, Martin Bendlova, Bela The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics |
title | The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics |
title_full | The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics |
title_fullStr | The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics |
title_full_unstemmed | The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics |
title_short | The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics |
title_sort | rs10830963 polymorphism of the mtnr1b gene: association with abnormal glucose, insulin and c-peptide kinetics |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207528/ https://www.ncbi.nlm.nih.gov/pubmed/35733780 http://dx.doi.org/10.3389/fendo.2022.868364 |
work_keys_str_mv | AT vejrazkovadaniela thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT vankovamarketa thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT vcelakjosef thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT krejcihana thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT anderlovakaterina thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT turaandrea thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT pacinigiovanni thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT sumovaalena thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT sladekmartin thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT bendlovabela thers10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT vejrazkovadaniela rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT vankovamarketa rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT vcelakjosef rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT krejcihana rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT anderlovakaterina rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT turaandrea rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT pacinigiovanni rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT sumovaalena rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT sladekmartin rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics AT bendlovabela rs10830963polymorphismofthemtnr1bgeneassociationwithabnormalglucoseinsulinandcpeptidekinetics |